2-165315472-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2

The NM_001040142.2(SCN2A):​c.1385C>T​(p.Ala462Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000411 in 1,461,464 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

SCN2A
NM_001040142.2 missense, splice_region

Scores

1
11
7
Splicing: ADA: 0.02364
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 5.48
Variant links:
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN2A. . Trascript score misZ 8.7114 (greater than threshold 3.09). GenCC has associacion of gene with seizures, benign familial infantile, 3, Dravet syndrome, benign familial neonatal-infantile seizures, malignant migrating partial seizures of infancy, complex neurodevelopmental disorder, developmental and epileptic encephalopathy, 11, developmental and epileptic encephalopathy, West syndrome, benign familial infantile epilepsy, episodic ataxia, type 9.
BP4
Computational evidence support a benign effect (MetaRNN=0.423316).
BS2
High AC in GnomAdExome4 at 60 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCN2ANM_001040142.2 linkuse as main transcriptc.1385C>T p.Ala462Val missense_variant, splice_region_variant 11/27 ENST00000375437.7 NP_001035232.1 Q99250-1
SCN2ANM_001371246.1 linkuse as main transcriptc.1385C>T p.Ala462Val missense_variant, splice_region_variant 11/27 ENST00000631182.3 NP_001358175.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCN2AENST00000375437.7 linkuse as main transcriptc.1385C>T p.Ala462Val missense_variant, splice_region_variant 11/275 NM_001040142.2 ENSP00000364586.2 Q99250-1
SCN2AENST00000631182.3 linkuse as main transcriptc.1385C>T p.Ala462Val missense_variant, splice_region_variant 11/275 NM_001371246.1 ENSP00000486885.1 Q99250-2
SCN2AENST00000283256.10 linkuse as main transcriptc.1385C>T p.Ala462Val missense_variant, splice_region_variant 11/271 ENSP00000283256.6 Q99250-1
SCN2AENST00000424833.5 linkuse as main transcriptc.1385C>T p.Ala462Val missense_variant, splice_region_variant 11/111 ENSP00000406454.2 F6U291

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.0000322
AC:
8
AN:
248128
Hom.:
0
AF XY:
0.0000297
AC XY:
4
AN XY:
134542
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000541
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000411
AC:
60
AN:
1461464
Hom.:
0
Cov.:
32
AF XY:
0.0000454
AC XY:
33
AN XY:
727032
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000477
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000468
Hom.:
0
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 23, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 586495). This missense change has been observed in individual(s) with autism spectrum disorder (PMID: 30564305). This variant is present in population databases (rs769825203, gnomAD 0.006%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 462 of the SCN2A protein (p.Ala462Val). -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsNov 17, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 08, 2020The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This substitution is predicted to be within the cytoplasmic loop between the first and second homologous domains; This variant is associated with the following publications: (PMID: 30564305) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
0.10
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.54
.;D;.;T;.;D;D;.
Eigen
Benign
0.10
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D;D;.;D;.;.;.;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.42
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.58
D
MutationAssessor
Benign
1.7
.;L;L;.;L;L;L;L
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.6
D;N;.;.;.;.;N;N
REVEL
Uncertain
0.48
Sift
Benign
0.098
T;T;.;.;.;.;T;T
Sift4G
Benign
0.11
T;T;.;.;T;.;T;T
Polyphen
0.0030, 0.0070
.;B;B;.;B;B;B;B
Vest4
0.52, 0.53, 0.53, 0.54
MutPred
0.42
Gain of catalytic residue at A462 (P = 0.0366);Gain of catalytic residue at A462 (P = 0.0366);Gain of catalytic residue at A462 (P = 0.0366);.;Gain of catalytic residue at A462 (P = 0.0366);Gain of catalytic residue at A462 (P = 0.0366);Gain of catalytic residue at A462 (P = 0.0366);Gain of catalytic residue at A462 (P = 0.0366);
MVP
0.94
ClinPred
0.11
T
GERP RS
5.9
Varity_R
0.071
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.024
dbscSNV1_RF
Benign
0.19
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs769825203; hg19: chr2-166171982; COSMIC: COSV51849419; COSMIC: COSV51849419; API